News - Zaltrap, Bayer


Current filters:


Popular Filters

Fast growth forecast for China’s colorectal cancer market

Fast growth forecast for China’s colorectal cancer market


From 2012 to 2017, the colorectal cancer therapy market in China will grow at an annual rate of 9%, from…

AmgenAsia-PacificBayerIndiaMarkets & MarketingOncologyPharmaceuticalSanofiStivargaVectibixZaltrap

Approved cancer drug potentially could help treat diabetes, Stanford researchers find


A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular…


US and European Rxing decisions on metastatic colorectal cancer


The effect of a therapy on overall survival and progression-free survival are attributes that most influence…

AvastinBayerEli LillyEuropeMarkets & MarketingNorth AmericaOncologyPharmaceuticalramucirumabRegeneronRocheSanofiStivargaZaltrap

Bayer's Stivarga races to FDA approval on the heels of Zaltrap


The earlier than expected US Food and Drug Administration approval of German drug major Bayer's (BAYN:…

BayerBiotechnologyMarkets & MarketingNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalregorafenibRegulationSanofiStivargaZaltrap

Back to top